Terence Hall

814 citations
17 papers · 528 · 1 hit paper · h-index 7

Impact in

    • Pancreatic and Hepatic Oncology Research
    • Peptidase Inhibition and Analysis
  • Surgery top 10%
    • Cholangiocarcinoma and Gallbladder Cancer Studies

Papers in

Terence Hall

14 papers receiving 521 citations

Terence Hall's Hit Papers

Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma 2018 · 268 citations
2680+2+5Years since publication50100150200250

Peers

Terence Hall
Comparison fields: 5 of 45
  • Oncology 189
  • Surgery 286
  • Pathology and Forensic Medicine 67
  • Molecular Biology 252
  • Pulmonary and Respiratory Medicine 91
Replace Julia Kazakin with:
Julia Kazakin United States
Jennifer Carter United States
Soo-Han Jun South Korea
Hannah M. Liebman United States
T. Macarulla Mercadé Spain
Aikseng Ooi Japan
Huizhong Qiu China
Yanwu Sun China
R. Delva France
Rita El‐Khoueiry United States
Terence Hall relative to Julia Kazakin United States Julia Kazakin's profile →
Citations per field
00.5×1.5×
Julia Kazakin · 1×
Citations per year

Countries citing papers authored by Terence Hall

Since Specialization
Citations

This map shows the geographic impact of Terence Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terence Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terence Hall more than expected).

Fields of papers citing papers by Terence Hall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terence Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terence Hall. The network helps show where Terence Hall may publish in the future.

Co-authors

The 25 scholars most cited alongside Terence Hall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Terence Hall Line = papers co-authored together Terence Hall links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma
Hit paper breakdown →
2018268
2 2015104
3 201677
4 201723
5 201722
6 201716
7 20158
8 20232
9 20232
10 20162
11 20251
12 20151
13 20181
14 20181
15 20150
16 20180
17 20240

About Terence Hall

Terence Hall is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Genetics and Pathology and Forensic Medicine, having authored 17 papers that have together received 528 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (6 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Advanced Breast Cancer Therapies (3 papers), Kruppel-like factors research (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Cancer Mechanisms and Therapy (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Oncology (189 citations), Surgery (286 citations), Pathology and Forensic Medicine (67 citations), Molecular Biology (252 citations) and Pulmonary and Respiratory Medicine (91 citations). Terence Hall has collaborated with scholars based in United States, Italy and Czechia. Frequent co-authors include Brian Schwartz, Giovanni Abbadessa, Sudharshan Eathiraj, Ronald E. Savage, Michael J. Wick, Julia Kazakin, Kyriakos P. Papadopoulos, Vincenzo Mazzaferro, Bassel F. El‐Rayes and Gianluca Masi. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, PLoS ONE, Molecular Cancer Therapeutics and Bone.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact